Cardiac Magnetic Resonance Imaging Midterm Follow Up of COVID-19 Vaccine–Associated Myocarditis

Cavalcante, João L.; Shaw, Kirsten E.; Gössl, Mario

doi:10.1016/j.jcmg.2022.01.008

Cited by 13 publications

(5 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Whether this iatrogenic catalyst of myocardial injury results in a similar duration and cumulative burden of inflammatory injury as compared to community-acquired viral myocarditis was previously unknown. Recently, a single case series of 5 subjects was published casting preliminary insights from convalescent CMR-based findings following mRNA COVID-19 vaccination induced injury 32 . In this study by Cavalcante, et al, all 5 patients showed LVEF normalization and resolution of myocardial edema (by T2 mapping) after a median follow up of 106 days.…”

Section: Discussionmentioning

confidence: 99%

Natural History of Myocardial Injury After COVID-19 Vaccine–Associated Myocarditis

Alhussein

Rabbani

Sarak

et al. 2022

Canadian Journal of Cardiology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Natural History of Myocardial Injury After COVID-19 Vaccine–Associated Myocarditis

Alhussein

Rabbani

Sarak

et al. 2022

Canadian Journal of Cardiology

View full text Add to dashboard Cite

“…This is important as it may mimic other cardiac disorders and therefore requires a high level of clinical suspicion. The utility of CMR in this patient population remains unclear, but it may offer a further cardiac evaluation to confirm the diagnosis or better characterize progression or resolution [ 58 ]. There are no guidelines available for managing COVID19VAM or COVID19VAP.…”

Section: Management Of Vaccine-induced Pericarditis and Myocarditismentioning

confidence: 99%

“…Majority of patients with myocardial and pericardial inflammation after the COVID-19 vaccine show complete resolution. A three-month follow-up of five patients with myocarditis after COVID19 vaccination showed normalization of ejection fraction and resolution of myocardial edema in all patients [ 58 ]. However, at this point, there remains a scarcity of long-term data for COVID-19 vaccine–related inflammatory heart conditions.…”

Section: Management Of Vaccine-induced Pericarditis and Myocarditismentioning

confidence: 99%

COVID-19 Vaccine–Related Myocardial and Pericardial Inflammation

et al. 2022

View full text Add to dashboard Cite

Purpose of Review To review myocarditis and pericarditis developing after COVID-19 vaccinations and identify the management strategies. Recent Findings COVID-19 mRNA vaccines are safe and effective. Systemic side effects of the vaccines are usually mild and transient. The incidence of acute myocarditis/pericarditis following COVID-19 vaccination is extremely low and ranges 2–20 per 100,000. The absolute number of myocarditis events is 1–10 per million after COVID-19 vaccination as compared to 40 per million after a COVID-19 infection. Higher rates are reported for pericarditis and myocarditis in COVID-19 infection as compared to COVID-19 vaccines. Summary COVID-19 vaccine–related inflammatory heart conditions are transient and self-limiting in most cases. Patients present with chest pain, shortness of breath, and fever. Most patients have elevated cardiac enzymes and diffuse ST-segment elevation on electrocardiogram. Presence of myocardial edema on T2 mapping and evidence of late gadolinium enhancement on cardiac magnetic resonance imaging are also helpful additional findings. Patients were treated with non-steroidal anti-inflammatory drugs and colchicine with corticosteroids reserved for refractory cases. At least 3–6 months of exercise abstinence is recommended in athletes diagnosed with vaccine-related myocarditis. COVID-19 vaccination is recommended in all age groups for the overall benefits of preventing hospitalizations and severe COVID-19 infection sequela.

show abstract

“…We present CMR imaging findings, as well as clinical characteristics, of 5 adult patients previously affected by COV19VAM. This is the first systematic longitudinal evaluation of both clinical and imaging data up to 3-month follow-up (median follow-up time from first CMR in this study was 106 days; IQR: 75.5-107.5 days) for patients with previous COV19VAM" [6].…”

mentioning

confidence: 94%

Sars Cov-2 Spike Protein- ACE receptor link, Graphene and Electro-Magnetic Field: toxicological aspetcs HYPOTESYS OF WORK

et al. 2023

Trends Gen Med

View full text Add to dashboard Cite

Related the profile of some toxicological aspect of some COVID -19 vaccine and in specifc way to the rare effect like pericarditis or trombosys are reported in this work some relevant literature involved in the effect played by the SPIKE PROTEINS and its link on epithelial tissue ACE receptor, the Graphene (if present) and under some magnetic field or electrical condition. An experimental hypotesys is submitted to the reseacher in order to produce a global conclusion of toxicological interest.

show abstract

Cardiac Magnetic Resonance Imaging Midterm Follow Up of COVID-19 Vaccine–Associated Myocarditis

Cited by 13 publications

References 3 publications

Natural History of Myocardial Injury After COVID-19 Vaccine–Associated Myocarditis

Natural History of Myocardial Injury After COVID-19 Vaccine–Associated Myocarditis

COVID-19 Vaccine–Related Myocardial and Pericardial Inflammation

Sars Cov-2 Spike Protein- ACE receptor link, Graphene and Electro-Magnetic Field: toxicological aspetcs HYPOTESYS OF WORK

Contact Info

Product

Resources

About